Gallbladder Adenocarcinoma, Potential Target for Anti-Her-2 Therapy
Sign Up to like & getrecommendations! Published in 2020 at "Acta medica Iranica"
DOI: 10.18502/acta.v58i5.3957
Abstract: Her-2 (ErbB-2) is an oncogene frequently overexpressed in breast and gastric adenocarcinomas, and anti-Her-2 targeted therapy can be given to such patients. Her-2 overexpression and role of anti-Her-2 targeted therapy in cases of gallbladder adenocarcinomas… read more here.
Keywords: therapy; potential target; adenocarcinoma potential; gallbladder ... See more keywords